FENNEC PHARMACEUTICALS INC. (FENC)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

2Y 5Y 10Y All
Quarterly Annual TTM

Revenue Annual

0 20M 40M 60M FY11: 0 FY12: 0 FY13: 0 FY14: 0 FY15: 0 FY16: 0 FY17: 0 FY18: 0 FY19: 0 FY20: 170K FY22: 1.5M FY23: 21.3M FY24: 47.5M FY25: 44.6M FY12 FY14 FY16 FY18 FY20 FY23 FY25

Gross Profit Annual

0 7M 14M 21M FY22: 1.4M FY23: 20M FY22 FY23

Operating Income Annual

-24M -16M -8M 0 8M 16M 24M FY10: -4.6M FY11: -3.4M FY12: -3.6M FY13: -1.9M FY14: -2.9M FY15: -1.9M FY16: -2.9M FY17: -7M FY18: -10.4M FY19: -13M FY20: -17.9M FY21: -17.2M FY22: -22.6M FY23: -12.8M FY24: 2.6M FY25: -6.3M FY11 FY13 FY15 FY17 FY19 FY21 FY23 FY25

Net Income Annual

-27M -18M -9M 0 9M 18M 27M FY05: -13.9M FY06: -16.4M FY07: -13.4M FY08: -13.6M FY09: -3M FY10: -7.8M FY11: 4.7M FY12: -5.2M FY13: 1.8M FY14: -2.2M FY15: -659K FY16: -2.8M FY17: -7M FY18: -9.9M FY19: -12.8M FY20: -18.1M FY21: -17.3M FY22: -23.7M FY23: -16M FY24: -436K FY25: -9.7M FY05 FY07 FY09 FY11 FY13 FY15 FY17 FY19 FY21 FY23 FY25

Cost of Revenue Annual

0 500K 1M 1.5M FY22: 86K FY23: 1.3M FY22 FY23

Operating Cash Flow Annual

-20M -10M 0 10M 20M 30M FY10: -1.9M FY11: -3.2M FY12: -3M FY13: -2.2M FY14: -1.7M FY15: -1.9M FY16: -2.1M FY17: -3.6M FY18: -7.8M FY19: -9.1M FY20: -15.6M FY21: -14.2M FY22: -18.1M FY23: -17.1M FY24: 27M FY25: -12.5M FY11 FY13 FY15 FY17 FY19 FY21 FY23 FY25

Free Cash Flow Annual

-4.5M -3M -1.5M 0 1.5M 3M 4.5M FY11: -3.2M FY12: -3M FY13: -2.2M FY11 FY12 FY13

Operating cash flow minus capital expenditure.

Shares Outstanding Annual

0 10M 20M 30M FY10: 16M FY11: 24.1K FY12: 25.2M FY13: 10.6M FY14: 9.9M FY15: 10.8M FY16: 12.8M FY17: 15M FY18: 18.9M FY19: 19.9M FY20: 23.7K FY21: 26M FY22: 26.3M FY23: 26.6M FY24: 27.3M FY25: 28.6M FY11 FY13 FY15 FY17 FY19 FY21 FY23 FY25

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-1.05 -0.70 -0.35 0.00 0.35 0.70 1.05 Q4 '11: 0.19 Q4 '13: 0.17 Q1 '14: 0.00 Q2 '14: -0.34 Q3 '14: -0.10 Q4 '14: -0.22 Q1 '15: 0.12 Q2 '15: 0.18 Q3 '15: 0.14 Q4 '15: -0.07 Q1 '16: -0.12 Q2 '16: -0.16 Q3 '16: -0.19 Q4 '16: -0.23 Q1 '17: -0.25 Q2 '17: -0.30 Q3 '17: -0.41 Q4 '17: -0.47 Q1 '18: -0.50 Q2 '18: -0.53 Q3 '18: -0.52 Q4 '18: -0.52 Q1 '19: -0.29 Q2 '19: -0.39 Q3 '19: -0.34 Q4 '19: -0.37 Q1 '20: -0.70 Q2 '20: -0.67 Q3 '20: -0.82 Q4 '20: -0.76 Q1 '21: -0.75 Q2 '21: -0.69 Q3 '21: -0.61 Q4 '21: -0.66 Q1 '22: -0.62 Q2 '22: -0.66 Q3 '22: -0.81 Q4 '22: -0.89 Q1 '23: -0.98 Q2 '23: -1.00 Q3 '23: -0.76 Q4 '23: -0.64 Q1 '24: -0.00 Q2 '24: 0.01 Q3 '24: -0.13 Q4 '24: -0.02 Q1 '25: -0.47 Q2 '25: -0.38 Q3 '25: -0.19 Q4 '25: -0.33 Q1 '26: -0.28 Q2 '26: -0.12 Q1 '14 Q4 '15 Q3 '17 Q2 '19 Q1 '21 Q4 '22 Q3 '24 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.